These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 16008584)

  • 21. Inactivation of Bacillus anthracis spores in murine primary macrophages.
    Hu H; Sa Q; Koehler TM; Aronson AI; Zhou D
    Cell Microbiol; 2006 Oct; 8(10):1634-42. PubMed ID: 16984418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative measurement of anthrax toxin receptor messenger RNA in primary mononuclear phagocytes.
    Premanandan C; Lairmore MD; Fernandez S; Phipps AJ
    Microb Pathog; 2006; 41(4-5):193-8. PubMed ID: 16854559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Where and how do anthrax toxins exit endosomes to intoxicate host cells?
    Puhar A; Montecucco C
    Trends Microbiol; 2007 Nov; 15(11):477-82. PubMed ID: 17983750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores.
    Cote CK; Rea KM; Norris SL; van Rooijen N; Welkos SL
    Microb Pathog; 2004 Oct; 37(4):169-75. PubMed ID: 15458777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting of Bacillus anthracis interaction factors for human macrophages using two-dimensional gel electrophoresis.
    Seo GM; Kim SJ; Kim JC; Nam DH; Yoon MY; Koo BS; Chai YG
    Biochem Biophys Res Commun; 2004 Sep; 322(3):854-9. PubMed ID: 15336541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes.
    Patel VI; Booth JL; Dozmorov M; Brown BR; Metcalf JP
    Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32698436
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA vaccination against anthrax in mice-combination of anti-spore and anti-toxin components.
    Hahn UK; Boehm R; Beyer W
    Vaccine; 2006 May; 24(21):4569-71. PubMed ID: 16157424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo.
    Scobie HM; Wigelsworth DJ; Marlett JM; Thomas D; Rainey GJ; Lacy DB; Manchester M; Collier RJ; Young JA
    PLoS Pathog; 2006 Oct; 2(10):e111. PubMed ID: 17054395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New insights into the functions of anthrax toxin.
    Banks DJ; Ward SC; Bradley KA
    Expert Rev Mol Med; 2006 Apr; 8(7):1-18. PubMed ID: 16608555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between anthrax toxin receptors and protective antigen.
    Scobie HM; Young JA
    Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a plasmid region involved in Bacillus anthracis toxin production and pathogenesis.
    Sirard JC; Guidi-Rontani C; Fouet A; Mock M
    Int J Med Microbiol; 2000 Oct; 290(4-5):313-6. PubMed ID: 11111904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs.
    Bozue JA; Parthasarathy N; Phillips LR; Cote CK; Fellows PF; Mendelson I; Shafferman A; Friedlander AM
    Microb Pathog; 2005 Jan; 38(1):1-12. PubMed ID: 15652290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages.
    Ruthel G; Ribot WJ; Bavari S; Hoover TA
    J Infect Dis; 2004 Apr; 189(7):1313-6. PubMed ID: 15031802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
    Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
    Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.
    Jeon JH; Kim YH; Choi MK; Kim KA; Lee HR; Jang J; Kim YR; Chun JH; Eo SK; Kim TS; Rhie GE
    BMC Microbiol; 2014 Dec; 14():300. PubMed ID: 25472474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of superoxide in the germination of Bacillus anthracis endospores.
    Baillie L; Hibbs S; Tsai P; Cao GL; Rosen GM
    FEMS Microbiol Lett; 2005 Apr; 245(1):33-8. PubMed ID: 15796976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.
    Wei W; Lu Q; Chaudry GJ; Leppla SH; Cohen SN
    Cell; 2006 Mar; 124(6):1141-54. PubMed ID: 16564009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
    Langer M; Duggan ES; Booth JL; Patel VI; Zander RA; Silasi-Mansat R; Ramani V; Veres TZ; Prenzler F; Sewald K; Williams DM; Coggeshall KM; Awasthi S; Lupu F; Burian D; Ballard JD; Braun A; Metcalf JP
    Infect Immun; 2012 Dec; 80(12):4374-87. PubMed ID: 23027535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthrax toxin: the long and winding road that leads to the kill.
    Abrami L; Reig N; van der Goot FG
    Trends Microbiol; 2005 Feb; 13(2):72-8. PubMed ID: 15680766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.